中文 / EN
News

News

新闻中心

2025-02
-14

A Prodrug-based Ultra-long Acting Injectable 505(b)(2) New Drug About to Enter Pivotal Clinical Trial

View Details
A Prodrug-based Ultra-long Acting Injectable 505(b)(2) New Drug About to Enter Pivotal Clinical Trial
2025-01
-23

Henovcom Is Invited to Give Presentation at the mRNA Summit

View Details
Henovcom Is Invited to Give Presentation at the mRNA Summit
2024-08
-02

Capping Agent LZCap® Completes FDA Registration, Accelerating Global mRNA Development

View Details
Capping Agent LZCap® Completes FDA Registration, Accelerating Global mRNA Development
2024-06
-24

Cell Reports：LZCap® Capped Multivalent mRNA Vaccine Study Shows 100% Immune Protection-1

View Details
Cell Reports：LZCap® Capped Multivalent mRNA Vaccine Study Shows 100% Immune Protection-1
2024-04
-28

Henovcom Is Invited to Give an Oral Presentation at TIDES USA

View Details
Henovcom Is Invited to Give an Oral Presentation at TIDES USA
2023-07
-19

3rd mRNA Based Therapeutics Summit USA

View Details
3rd mRNA Based Therapeutics Summit USA
12